Expression and correlation of endoglin, sEndoglin, and MMP-14 on preeclampsia placenta
Abstract
Background: Hypertensive disorders, particularly preeclampsia, are major contributors to maternal mortality and neonatal morbidity. Angiogenic imbalance plays a critical role in placental ischemia, a hallmark of preeclampsia.
Purpose: This study aimed to investigate the roles of endoglin, soluble endoglin (sEndoglin), and matrix metalloproteinase-14 (MMP-14) in the angiogenic imbalance observed in preeclampsia placentas compared to normal-term placentas.
Method: A cross-sectional study was conducted using 68 placental samples: 34 from normal-term pregnancies and 34 from preeclampsia cases. Concentrations of endoglin, sEndoglin, and MMP-14 were measured using the sandwich ELISA method, and protein levels were determined using the Christian Warburg method. Data were analyzed using SPSS version 20.
Results: The concentration of endoglin in preeclampsia placentas was slightly higher (1.37 [0.2–2.2] ng/μg protein) compared to normal placentas (1.12 [0.6–14.1] ng/μg protein), although the difference was not statistically significant. In contrast, sEndoglin (0.05 [0.0–0.01] ng/μg protein vs. 0.02 [0.0–0.3] ng/μg protein) and MMP-14 (0.14 [0.1–0.6] ng/μg protein vs. 0.11 [0.1–1.3] ng/μg protein) concentrations were significantly higher in preeclampsia placentas compared to normal placentas. All parameters showed a gradual decrease with advancing gestational age. sEndoglin and MMP-14 demonstrated a strong positive correlation (r = 0.658, p < 0.001), while endoglin and MMP-14 exhibited a moderate positive correlation (r = 0.554, p < 0.001).
Conclusion: Endoglin, sEndoglin, and MMP-14 were differentially expressed in preeclampsia placentas, with sEndoglin and MMP-14 significantly elevated. These findings highlight their potential role in angiogenic imbalance and may provide insight into the pathophysiology of preeclampsia.
References
Organization WH. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011.
Indonesia Ro. Policy and enabling environment. Voluntary National Review (VNR) "Eradicating Poverty and Promoting Prosperity in a Changing World"2017. p. 5-100.
Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24(3):147-58. https://doi.org/10.1152/physiol.00043.2008
Ngene NC, Moodley J. Role of angiogenic factors in the pathogenesis and management of pre-eclampsia. International Journal of Gynecology and Obstetrics. 2018;141(1):5-13. https://doi.org/10.1002/ijgo.12424
Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Margaritis K, Vavoulidis E, Gullo G, et al. The role of endoglin and its soluble form in pathogenesis of preeclampsia. Mol Cell Biochem. 2022;477(2):479-91. https://doi.org/10.1007/s11010-021-04294-z
Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022;226(2S):S1019-S34. https://doi.org/10.1016/j.ajog.2020.10.022
Espino YSS, Flores-Pliego A, Espejel-Nunez A, Medina-Bastidas D, Vadillo-Ortega F, Zaga-Clavellina V, et al. New Insights into the Role of Matrix Metalloproteinases in Preeclampsia. Int J Mol Sci. 2017;18(7). https://doi.org/10.3390/ijms18071448
Abadi KC, Iswanti FC, Jusman SWA, Fadilah F, Prijanti AR. Spirulina platensis effect on oxidative stress of rat's offspring brain exposed to cigarette smoke during pregnancy and lactation. Acta Biochimica Indonesiana. 2022;5(1). https://doi.org/10.32889/actabioina.64
Elabscience. Human sENG(soluble endoglin) Elisa Kit. 2017.
Elabscience. Human ENG (endoglin) Elisa kit. 2017.
Elabscience. Human MMP-14 (Matix metallo proteinase-14) Elisa kit. 2017.
Ridwan R, Iswanti FC, Sadikin M. The increase of carbonic anhydrase in liver tissue of rat induced by chronic systemic hypoxia. Acta Biochimica Indonesiana. 2018;1(1). https://doi.org/10.32889/actabioina.v1i1.1
Armaly Z, Jadaon JE, Jabbour A, Abassi ZA. Preeclampsia: Novel mechanisms and potential therapeutic approaches. Frontiers in Physiology. 2018;9(JUL). https://doi.org/10.3389/fphys.2018.00973
Eastabrook G, Aksoy T, Bedell S, Penava D, de Vrijer B. Preeclampsia biomarkers: An assessment of maternal cardiometabolic health. Pregnancy Hypertension. 2018;13:204-13. https://doi.org/10.1016/j.preghy.2018.06.005
Saito T, Bokhove M, Croci R, Zamora-Caballero S, Han L, Letarte M, et al. Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1. Cell Reports. 2017;19(9):1917-28. https://doi.org/10.1016/j.celrep.2017.05.011
Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clinical Journal of the American Society of Nephrology. 2007;2(3):543-9. https://doi.org/10.2215/CJN.03761106
Schmella MJ, Roberts JM, Conley YP, Ren D, Storvold GL, Ingles SA, et al. Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts. Pregnancy Hypertension. 2018;12:144-9. https://doi.org/10.1016/j.preghy.2017.10.005
Fang M, He Y, Li H, Wu M, Shi X, Du H. Alterations of serum and placental endoglin in pre-eclampsia. Journal of International Medical Research. 2010;38(1):43-51. https://doi.org/10.1177/147323001003800105
Cui L, Shu C, Liu Z, Tong W, Cui M, Wei C, et al. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia. Pregnancy Hypertension. 2018;13:127-32. https://doi.org/10.1016/j.preghy.2018.05.011
Gaber K, Hamdy E, Hanafy A. Soluble Endoglin as a new marker for prediction of pre-eclampsia in early pregnancy. Middle East Fertility Society Journal. 2010;15(1):42-6. https://doi.org/10.1016/j.mefs.2010.03.009
Helmo FR, Lopes AMM, Carneiro ACDM, Campos CG, Silva PB, dos Reis Monteiro MLG, et al. Angiogenic and antiangiogenic factors in preeclampsia. Pathology Research and Practice. 2018;214(1):7-14. https://doi.org/10.1016/j.prp.2017.10.021
Sosa SEY, Flores-Pliego A, Espejel-Nuñez A, Medina-Bastidas D, Vadillo-Ortega F, Zaga-Clavellina V, et al. New insights into the role of matrix metalloproteinases in preeclampsia. International Journal of Molecular Sciences. 2017;18(7). https://doi.org/10.3390/ijms18071448
Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer research. 2010:0008-5472. CAN-09-4466. https://doi.org/10.1158/0008-5472.CAN-09-4466
Kaitu'U-Lino TJ, Palmer KR, Whitehead CL, Williams E, Lappas M, Tong S. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. American Journal of Pathology. 2012;180(3):888-94. https://doi.org/10.1016/j.ajpath.2011.11.014
Kaitu'u-Lino TJ, Palmer K, Tuohey L, Ye L, Tong S. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. PLoS ONE. 2012;7(6). https://doi.org/10.1371/journal.pone.0039864
Klose A, Zigrino P, Mauch C. Monocyte/macrophage MMP-14 modulates cell infiltration and T-cell attraction in contact dermatitis but not in murine wound healing. Am J Pathol. 2013;182(3):755-64. https://doi.org/10.1016/j.ajpath.2012.11.028
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
